Detalhe da pesquisa
1.
A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine.
J Med Virol
; 96(3): e29454, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445768
2.
A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine.
Front Immunol
; 15: 1374486, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745651
3.
NS1 Protein N-Linked Glycosylation Site Affects the Virulence and Pathogenesis of Dengue Virus.
Vaccines (Basel)
; 11(5)2023 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243063
4.
Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice.
Front Immunol
; 14: 1142394, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37006275
5.
An mRNA vaccine against rabies provides strong and durable protection in mice.
Front Immunol
; 14: 1288879, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37954577
6.
Construction of a Dengue NanoLuc Reporter Virus for In Vivo Live Imaging in Mice.
Viruses
; 14(6)2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35746724
7.
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice.
Emerg Microbes Infect
; 11(1): 1890-1899, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35775819